Clin2
NCT05867329Possibly a fitRecruiting

Comparing treatments for severe ulcerative colitis flare-ups

Ulcerative Colitis Acute

Treatments studied

Part of Digestive system clinical trials.

This study compares different sequences of medicines for treating severe ulcerative colitis flares in the hospital. It aims to find the best way to get your symptoms under control and help you feel better faster.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
700 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are between 18 and 75 years old.
  • You have ulcerative colitis and are currently in the hospital for a severe flare-up.
  • You are about to start or have just started IV steroids.
  • You have had at least 4 bloody bowel movements per day and other signs of severe disease (like fever, fast heart rate, or low blood counts).
  • You have previously been treated with a biologic medicine (like adalimumab, infliximab, or similar) or are unable to take these medicines.
  • You must be able to take oral medicines and keep up with study visits and daily symptom surveys.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07258771Recruiting· Phase 4
Upadacitinib plus steroids vs steroids alone for severe ulcerative colitis

This trial tests if adding upadacitinib (a pill) to standard steroid treatment helps people with a severe flare of ulcerative colitis feel better faster. You may qualify if you are having frequent bloody stools and signs of serious inflammation, and you haven't tried upadacitinib before.

Ann Arbor, Michigan
NCT06660693Recruiting· Phase 3
Comparing rescue treatments for severe ulcerative colitis flare

This trial tests two different medicines, infliximab and upadacitinib, to see which works better for people with severe ulcerative colitis that hasn't improved after 3 days of IV steroids. The goal is to find the best rescue option to help you feel better and avoid surgery.

Hamilton, Ontario
NCT06420492Recruiting· Phase 2
New treatments for severe ulcerative colitis flare

This trial tests new therapies for people with a severe UC flare that hasn't improved after 5 days of high-dose steroids. It aims to find more effective options to control symptoms and avoid hospitalization.

Chestnut Hill, Massachusetts
NCT07546097Recruiting· Phase 4
Upadacitinib vs Steroids for Severe Ulcerative Colitis

This study compares a newer medication called upadacitinib to traditional steroids for treating acute severe ulcerative colitis (sudden worsening of UC with bloody diarrhea and urgent symptoms). The goal is to see which approach works better as a first treatment.

Ankang, Shaanxi
NCT06953791Recruiting· Phase 2
Comparing two treatments for Crohn's disease flare-ups

This trial compares a steroid called prednisolone to a special diet (aCDED with PEN) for treating Crohn's disease flare-ups. It aims to see which approach helps improve quality of life.

Tübingen
NCT07502339Not yet recruiting· Phase 4
Upadacitinib for severe ulcerative colitis in hospital

This trial tests a medication called upadacitinib for people hospitalized with a severe ulcerative colitis flare. It could help control inflammation and reduce symptoms.

San Francisco, California

Hear when a new Ulcerative Colitis Acute trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.